Search results
Dublin, Ireland, July 27th, 2018 – ICON plc (NASDAQ: ICLR ), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today confirmed, that Dr. Ronan Lambe retired as a non-executive director at the Annual General Meeting (AGM) of the Company on the 24th July 2018.
Dr. Lambe is co-founder of Afimmune, a biotech specialising in metabolic diseases and DS Biopharma, a dermatology research company. Dr. Lambe is also a co-founder of ICON plc, one of the world’s largest contract clinical research organizations where he served as Executive Chairman.
Ronan Lambe. Partner. +44 (0)131 777 7077. ronan.lambe@pinsentmasons.com. Edinburgh. Make an Enquiry. Ronan has considerable experience advising clients on energy projects, with a particular focus on renewables and cleantech.
- Pinsent Masons 58 Morrison Street Edinburgh EH3 8BP
- ronan.lambe@pinsentmasons.com
- 0131 777 7077
- Partner
Jul 31, 2018 · Icon PLC, a clinical research organization, has confirmed that co-founder Ronan Lambe is stepping down as nonexecutive director after 28 years with the Dublin-based company. The company officially announced Lambe's retirement at their annual general meeting July 24, following a statement in June that Lambe would not be seeking re-election.
After 28 years of Service
Jul 27, 2018 · CEO Dr. Steve Cutler commented, “I would like to recognize the immense contribution of Dr. Ronan Lambe, ICON’s co-founder with Dr. John Climax, who after 28 years of service, has retired from...
May 22, 2004 · Icon co-founder and retired chairman Dr Ronan Lambe has raised more than €8.5 million from the sale of 1.6 per cent of his shareholding. Dr Lambe sold 219,723 shares at a price of €38.88 each...
